PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 25 filers reported holding PROQR THRAPEUTICS N V in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,058,000 | -5.5% | 344,320 | -0.8% | 0.06% | -38.2% |
| Q4 2017 | $1,120,000 | +471.4% | 347,245 | +768.1% | 0.10% | +827.3% |
| Q4 2016 | $196,000 | -50.1% | 40,000 | -32.1% | 0.01% | -26.7% |
| Q3 2016 | $393,000 | -26.1% | 58,910 | -46.4% | 0.02% | -46.4% |
| Q2 2016 | $532,000 | -27.3% | 110,000 | -26.6% | 0.03% | -24.3% |
| Q1 2016 | $732,000 | +111.6% | 149,934 | +276.0% | 0.04% | +94.7% |
| Q4 2015 | $346,000 | +8.1% | 39,871 | +81.6% | 0.02% | +46.2% |
| Q3 2015 | $320,000 | -76.9% | 21,950 | -73.6% | 0.01% | -74.0% |
| Q2 2015 | $1,384,000 | -49.1% | 83,000 | -33.3% | 0.05% | -55.8% |
| Q1 2015 | $2,721,000 | -50.4% | 124,380 | -50.9% | 0.11% | -34.7% |
| Q4 2014 | $5,484,000 | -16.3% | 253,083 | -33.6% | 0.17% | -31.3% |
| Q3 2014 | $6,554,000 | – | 381,249 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |